Rheumatologic disease activity an important influencer of COVID-19 death risk
February 5, 2021
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from COVID-19.
COVID-19 risks in rheumatic disease remain unclear
November 7, 2020
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
ACIP approves flu vaccine recommendations for 2020-2021
June 25, 2020
Next season’s vaccination options include new high-dose quadrivalent vaccines for seniors.
EULAR’s COVID-19 recommendations offer no surprises
June 11, 2020
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and those with the infection, and preventing COVID-19 lookalikes.
Age leads COVID-19 hospitalization risk factors in RMDs
June 10, 2020
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in inflammatory rheumatic diseases.
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
June 4, 2020
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
TNF inhibitors may dampen COVID-19 severity
May 19, 2020
New findings from the COVID-19 Global Rheumatology Alliance Registry.
Advice on treating rheumatic diseases from a COVID-19 epicenter
May 13, 2020
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during the COVID-19 pandemic.
ACR gives guidance on rheumatic disease management during pandemic
May 12, 2020
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be stopped or held.
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.